Literature DB >> 23302522

A new carbamate with cytotoxic activity from the aerial parts of Siegesbeckia pubecens.

Jia Liu1, Rong Chen, Yu Nie, Lin Feng, Hai-Dao Li, Jing-Yu Liang.   

Abstract

AIM: To study the chemical constituents of Siegesbeckia pubescens.
METHODS: The chemical constituents were isolated by extraction, crystallization and various chromatographic methods, and the chemical structures were elucidated on the basis of spectral analysis. In addition, the cytotoxic activity of compound 1 was evaluated using human lung cancer cell A 549.
RESULTS: Four compounds were obtained, and their structures were identified as (E)-3-(3-oxobut-1-enyl)phenyl dimethylcarbamate (1), ent-2-oxo-15, 16, 19-trihydroxypimar-8(14)-ene (2), 16-acetylkirenol (3), 3, 7-dimethylquercetin (4).
CONCLUSION: Compound 1 is a new carbamate, and the IC(50) in MTT method of compound 1 was 58 μg·mL(-1).
Copyright © 2012 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23302522     DOI: 10.1016/S1875-5364(12)60002-8

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  3 in total

1.  Anti-Inflammatory Effect of Three Isolated Compounds of Physalis alkekengi var. franchetii (PAF) in Lipopolysaccharide-Activated RAW 264.7 Cells.

Authors:  Hyun-Jung Park; Hyun Soo Shim; Ah-Reum Han; Eun-Kyoung Seo; Kyu-Ri Kim; Bong Hee Han; Insop Shim
Journal:  Curr Issues Mol Biol       Date:  2022-03-21       Impact factor: 2.976

2.  Comparison of the chemical profiles and inflammatory mediator-inhibitory effects of three Siegesbeckia herbs used as Herba Siegesbeckiae (Xixiancao).

Authors:  Hui Guo; Yi Zhang; Brian Chi-Yan Cheng; Mei-Yuk Lau; Xiu-Qiong Fu; Ting Li; Tao Su; Pei-Li Zhu; Yuen-Cheung Chan; Anfernee Kai-Wing Tse; Tao Yi; Hu-Biao Chen; Zhi-Ling Yu
Journal:  BMC Complement Altern Med       Date:  2018-05-02       Impact factor: 3.659

3.  Study on the Multitarget Mechanism and Key Active Ingredients of Herba Siegesbeckiae and Volatile Oil against Rheumatoid Arthritis Based on Network Pharmacology.

Authors:  Xin Yang; Yahui Li; Runlin Lv; Haibing Qian; Xiangyun Chen; Chang Fu Yang
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-26       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.